Robotic-assisted surgery for mid and low rectal cancer: a long but safe learning curve

被引:0
作者
Sophie Zaepfel
Raluca Marcovei
Elena Fernandez-de-Sevilla
Isabelle Sourrouille
Charles Honore
Maximiliano Gelli
Matthieu Faron
Leonor Benhaim
机构
[1] Gustave Roussy Cancer Center,Department of Surgical Oncology
[2] Inserm,Oncostat U1018
[3] Université Paris-Saclay,Centre de Recherche Des Cordeliers
[4] Équipe Labellisée Ligue Contre le Cancer,undefined
[5] INSERM,undefined
[6] Sorbonne Université,undefined
[7] Université de Paris,undefined
[8] Equipe Labellisée Ligue Nationale Contre le Cancer,undefined
[9] CNRS SNC 5096,undefined
来源
Journal of Robotic Surgery | 2023年 / 17卷
关键词
Learning curve; Robotic-assisted surgery; Rectal cancer; LC-CUSUM; Training program; Proctectomy;
D O I
暂无
中图分类号
学科分类号
摘要
The number of robotic-assisted procedures for rectal cancer is rising. The risk of this procedure when performed by surgeon with limited robotic experience is unknown and the precise duration of the learning curve debated. We, therefore, aimed to analyze the learning curve and its related safety in a single center before the development of mentoring programs. We prospectively recorded all robotic procedures performed for colorectal cancer between 2015 and 2020 by a single surgeon. Operative times for partial and total proctectomy were analyzed. The learning curve was defined by comparison with the standard duration of the laparoscopic procedure performed in expert centers (published in GRECCAR 5 and GRECCAR 6 trials) and calculated using a cumulative summation for learning curve test (LC-CUSUM). Among the 174 patients operated for colorectal cancer, we analyzed the outcomes of the 89 patients operated by partial and total robotic proctectomy. To reach repeatedly the same surgical duration as laparoscopic procedure for partial or complete proctectomy, the LC-CUSUM identified a learning curve of 57 patients. A severe morbidity in this population, defined by Clavien–Dindo classification ≥ 3, was observed in 15 cases (16.8%) with an anastomotic leak rate of 13.5%. The rate of completeness of mesorectal excision was 90% and the mean number of harvested lymph nodes was 15 (± 9). Using operative time as end-point, the learning curve of rectal cancer robotic surgery identified a cut-off of 57 patients. The technic remained safe with acceptable morbidity and oncological outcomes.
引用
收藏
页码:2099 / 2108
页数:9
相关论文
共 310 条
  • [1] Hazebroek EJ(2002)COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer Surg Endosc 16 949-953
  • [2] Green BL(2013)Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer Br J Surg 100 75-82
  • [3] Marshall HC(2005)Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique Br J Surg 92 1124-1132
  • [4] Collinson F(2015)Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial JAMA 314 1356-1363
  • [5] Quirke P(2015)Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial JAMA 314 1346-1355
  • [6] Guillou P(2005)Advantages and limits of robot-assisted laparoscopic surgery: preliminary experience Surg Endosc 19 117-119
  • [7] Jayne DG(2003)Comparison of robotically performed and traditional laparoscopic colorectal surgery Dis Colon Rectum 46 1633-1639
  • [8] Brown JM(2010)Robotic colorectal surgery: hype or new hope? A systematic review of robotics in colorectal surgery Colorectal Dis 12 1084-1093
  • [9] Jayne DG(2019)European consensus on the standardization of robotic total mesorectal excision for rectal cancer Colorectal Dis 21 270-276
  • [10] Brown JM(2022)Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial Lancet Gastroenterol Hepatol. 7 991-1004